Common complications during hemodialysis include hypotension, muscle cramps, nausea/vomiting, and headaches. Hypotension occurs in 15-50% of sessions and can be caused by rapid fluid removal, autonomic dysfunction, or cardiac issues. Muscle cramps affect up to 90% of patients and may be caused by electrolyte imbalances. Nausea and headaches are often associated with hypotension. Other potential issues include chest pain, air embolism, and hemolysis. Preventing complications focuses on gradual fluid removal and treatment of underlying causes.
Hyertension in patients on regular hemodialysisEhab Ashoor
Everything about hypertension in patients on regular hemodialysis, including management, Resistant hypertension, Intra-dialytic hypertension and Hypertensive urgencies.
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
Hyertension in patients on regular hemodialysisEhab Ashoor
Everything about hypertension in patients on regular hemodialysis, including management, Resistant hypertension, Intra-dialytic hypertension and Hypertensive urgencies.
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
Steal syndrome
• Dialysis access–associated hand ischemia, “steal syndrome,” complicates 1%–20% of accesses
• Is stealing سرقة of (arterial) blood which would normally flow to the palmar arch.
• Common in upper arm AVFs (~4%) compared with both AVGs and forearm AVFs (~1%).
• Risk factors
Upper arm access
Peripheral arterial disease
Diabetes
• Patient can complain of:
Hand numbness, pain, or weakness
Cold sensation and pale or cyanosis of the fingers
Diminished or absent pulses
Ulceration or dry gangrene of the finger tips in severe cases infection.
Pt start to wear gloves in fistula hand
• Examination requires comparison with the temperature, pulse, and function of the opposite hand.
• Investigations
Pulse oximetry
Doppler flow
Angiography
• Differential diagnosis
Carpal tunnel syndrome
Peripheral vascular disease
Neuropathy DM or Uremia
Nerve trauma
Ischemic monomelic neuropathy due to the loss of blood supply to nerves.
• Treatment Options (Depending on Severity)
Symptomatic coldness or paresthesia but without sensory or motor loss (e.g., gloves)
Surgical, with preservation of vascular access- in "steal” effect (pain at rest) or the appearance of nonhealing ulcers: banding to reduce flow, distal revascularization–interval ligation (DRIL) procedure
Surgical, with loss of vascular access- in motor loss: ligation
Renal papillary necrosis ( RPN)
• Definition
o Disorder of the kidneys in which all or part of the renal papillae die.
• Causes
Analgesic nephropathy
Diabetic nephropathy
Kidney infection (pyelonephritis)
Sickle cell anemia (common cause of RPN in children)
Urinary tract obstruction
Renal tuberculosis
Renal vein thrombosis
Kidney transplant rejection
• Symptoms
Dysuria, painful urination.
Fever and chills.
Hematuria, macroscopic or microscopic.
Nocturia, frequent urination at night.
Pyuria, unusually high amount of white blood cells in urine.
Severe flank pain on either side of your back.
Urinary tract infections.
• Diagnosis
Urography involves an X-ray, CT scan or MRI of kidneys. (Radiologic findings include an irregular papillary tip; dilated calyceal fornix; extension of contrast material into the parenchyma; and a separated crescent-shaped papilla surrounded by contrast, called the ring sign
Ureteroscopy
Kidney biopsy
Kidney function tests
Urinalysis red blood cells and broken-off pieces of renal papillae
• Complications:
Kidney infection
Kidney stones
Chronic kidney disease (CKD)
Transitional cell cancer of the kidney or ureter.
• Prevention
Controlling diabetes or sickle cell anemia.
Use only the recommended dose of analgesic
• Treatment
There is no specific treatment for renal papillary necrosis.
Treatment depends on the cause.
Cerebral Salt Wasting (CSW)
• Typically associated with subarachnoid hemorrhage,
• The causes may be:
o Impaired sympathetic neural input (SNS normally promotes proximal tubular Na, uric acid, and water reabsorption and renin–aldosterone release),
o Increased brain natriuretic peptide → impairs renal tubular Na reabsorption and inhibits renin release
• Clinical manifestations:
o Volume depletion,
o Orthostatic hypotension
• Laboratory findings:
o Hyponatremia,
o Low serum uric acid,
o high urine osmolality,
o U [Na] > 40 mmol/L,
o low renin and aldosterone levels (similar to those seen with SIADH)
• CSW patients present with volume depletion, in contrast to
SIADH patients who present with euvolemia or mild hypervolemia.
• Treatment of CSW:
o Volume repletion (NS)
(Note: NS may worsen hyponatremia in SIADH but would improve hyponatremia in CSW.
o Consider mineralocorticoids, for example, fludrocortisone 0.2 mg twice daily.
• Common features between SIADH and CSW:
o High ADH and Natriuretic peptide levels.
o High U [Na].
o Low renin and aldosterone levels.
o Low uric acid levels.
o ADH level decreases after volume repletion in CSW but not in SIADH.
Diabetic Ketoacidosis/Hyperosmolar Coma in ESRD
• Clinical Picture of hyperglycemia is modified (due to absence of renal function).
o The absence of polyuria and glycosuria “safety valve” severe hyperglycemia (serum glucose level >1,000 mg/dL)
o Alteration of mental status is unusual (Due to absence of water loss induced by osmotic diuresis).
o Asymptomatic mostly in spite of severe hyperglycemia
o Thirst, weight gain, and may be pulmonary edema or coma
o Severe hyperkalemia in DKA in insulin-dependent dialysis patients.
• Diagnosis in the ESKD patient is based on hyperglycemia, positive serum ketones, metabolic acidemia, and an increased anion gap.
o Which is not easy due to the plasma reaction for ketones may be negative, the anion gap may not be affected and the clinical presentation itself of severe hyperglycemia and ketoacidosis are atypical.
• Management of hyperglycemia with or without ketoacidosis differs from that in patients without renal failure in that administration of large amounts of fluid is unnecessary and generally contraindicated.
o Insulin is the only treatment needed can correct all clinical and laboratory abnormalities of hyperglycemia.
o Can administer a continuous infusion of low-dose regular insulin (starting at 2 units/hr) with close clinical monitoring and measurement of serum glucose and potassium concentrations at 2- to 3-hour intervals.
o Urgent dialysis if pulmonary edema and hyperkalemia.
• IV bicarbonate is not indicated may exacerbate volume overload.
• No phosphate replacement is generally needed.
• Hypophosphatemia is not expected.
• Magnesium deficiency is absent.
Emphysematous pyelonephritis
• Def: Life-threatening necrotizing acute pyelonephritis and/or obstruction, predominantly seen in diabetic patients
• Causes: Mostly gas-forming organisms such as Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Proteus mirabilis
• Symptoms of pyelonephritis and may be a flank mass.
• Urine analysis→ Pyuria and a positive urine culture
• Diagnosis: Gas pockets may be detected on plain abdominal radiograph, ultrasound, or CT.
• CT is the diagnostic modality of choice
• Management: Parenteral broad-spectrum antibiotics and percutaneous catheter drainage with relief of obstruction may be adequate for less severely ill patients, but nephrectomy in severely ill or not responding to other line of medication
• Medical treatment is associated with mortality of 60% to 80%,
Xanthogranulomatous pyelonephritis
• Def: Condition associated with chronic obstruction (e.g., staghorn calculi) and urinary tract infections with resulting destructive granulomatous inflammation
• CT: low-density masses with calcifications mimicking renal malignancy
• Histology: granulomatous inflammation with diffuse cellular infiltrate of lipid-laden foam cells (lipid-laden macrophages)→ replacing normal renal parenchyma
• Clinical manifestations: commonly affect middle-aged women who may present with fevers/chills, chronic flank pain, and, possibly, palpable mass.
• Urine cultures: may reveal gram-negative organisms such as E. coli, Klebsiella, or Proteus and, less commonly, Staphylococcal species.
• Management: organism-specific antibiotics, relief of obstruction, but total or partial nephrectomy as needed
Sickle cell nephropathy (SCN) is presence of sickled erythrocytes in the renal medulla that result in decreased medullary blood flow, ischemia, microinfarcts and papillary necrosis in the kidneys
Hepatitis C virus infection is associated with many renal diseases. Renal disease caused by :•Virus itself •Drugs used for treatment of hepatitis c •Associated condition with hepatitis → advanced liver cell failure.
Hepatitis C virus infection is associated with many renal diseases.
Renal disease caused by
• Virus itself
• Drugs used for treatment of hepatitis c
• Associated condition with hepatitisadvanced liver cell failure.
A. The renal disease associated with hepatitis c due to advanced liver cell failure:
• Prerenal (Hypovolemia , shock and hepatorenal syndrome )
• ATN ( sepsis or shock)
B. Drugs used for treatment of hepatitis c:
• Interstitial nephritis secondary to Interferon
C. Hepatitis c itself
o Hepatitis c is RNA flavivirus( single strand)
o Has extrahepatic manifestation like arthritis, DM, cryglobulinemia and glomerulonephritis
o Renal diseases associated with hepatitis C
1. The most common types is MPGN with cryoglobulinemia
2. Others are
MPGN without cryoglobulinemia
Membranous nephropathy (MN)
Focal segmental glomerulosclerosis
IgA nephropathy
Fibrillary glomerulopathy
Immunotactoid glomerulopathy
Thrombotic microangiopathy
Amyloid
Vasculitis
Interstitial nephritis secondary to virus
HCV-associated PAN
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
6. HypotensionHypotension
15-50% of dialysis sessions and15-50% of dialysis sessions and
can be episodic or, less commonly,can be episodic or, less commonly,
persistentpersistent
causes:causes:
7. @-Treatment-specific causes@-Treatment-specific causes
1-Rapid fluid removal (high UF rate)1-Rapid fluid removal (high UF rate)
2-Antihypertensive agent use2-Antihypertensive agent use
3-Rapid reduction in plasma osmolality3-Rapid reduction in plasma osmolality
(leading to water movement from the(leading to water movement from the
vascular into interstitial compartment)vascular into interstitial compartment)
4-Warm dialysate4-Warm dialysate
5-Low sodium dialysate5-Low sodium dialysate
6-Low dialysate osmolarity6-Low dialysate osmolarity
7-Use of acetate as buffer (a vasodilator)7-Use of acetate as buffer (a vasodilator)
8. @-Patient-specific causes@-Patient-specific causes
1-Diabetes1-Diabetes
2-Autonomic neuropathy2-Autonomic neuropathy
3-Reduced cardiac reserve (especially LVH3-Reduced cardiac reserve (especially LVH
and diastolic dysfunction)and diastolic dysfunction)
4-Arrhythmias4-Arrhythmias
5-Poor nutritional state5-Poor nutritional state
6-High weight gain6-High weight gain
7-Ingestion of food during dialysis (increased7-Ingestion of food during dialysis (increased
splanchnic venous pooling)splanchnic venous pooling)
8-Antihypertensive agents impairing cardiac8-Antihypertensive agents impairing cardiac
stability and reflexesstability and reflexes
9. @-Less common causes of@-Less common causes of
hypotensionhypotension
1-Pericardial effusion or tamponade.1-Pericardial effusion or tamponade.
2-Reactions to dialysis membranes.2-Reactions to dialysis membranes.
3-Increased dialysate magnesium.3-Increased dialysate magnesium.
4-GI bleeding.4-GI bleeding.
5-Disconnection of blood lines.5-Disconnection of blood lines.
6-MI.6-MI.
7-Haemolysis.7-Haemolysis.
8-Air embolism8-Air embolism
11. Episodes of hypotension can lead to morbidity, andEpisodes of hypotension can lead to morbidity, and
contribute to cardiovascular mortality.contribute to cardiovascular mortality.
Immediate management requires volumeImmediate management requires volume
resuscitation:resuscitation:
1-place patient head-down;1-place patient head-down;
2-administer 100 ml bolus of normal saline (some2-administer 100 ml bolus of normal saline (some
units use 10 ml of 23% saline, 30 ml 7.5% saline, 50units use 10 ml of 23% saline, 30 ml 7.5% saline, 50
ml 20% mannitol or albumin solutions);ml 20% mannitol or albumin solutions);
3-reduce UF rate to zero;3-reduce UF rate to zero;
if BP does not normalize rapidly, further saline mayif BP does not normalize rapidly, further saline may
be givenbe given..
12. If hypotension occurs repeatedlyIf hypotension occurs repeatedly
review:review:
1-dry weight (too low?)1-dry weight (too low?)
2-use of short-acting antihypertensive2-use of short-acting antihypertensive
3-UF rate;3-UF rate;
4-weight gains between sessions4-weight gains between sessions
5-dialysate sodium (keep above plasma5-dialysate sodium (keep above plasma
sodium);sodium);
6-use bicarbonate not acetate dialysate6-use bicarbonate not acetate dialysate
7-lower dialysate temperature to 34-36 C7-lower dialysate temperature to 34-36 C
8-increase Hb.8-increase Hb.
9-avoid food intake during dialysis.9-avoid food intake during dialysis.
16. Occur in up to 90% of dialysisOccur in up to 90% of dialysis
treatments, mainly towards the end oftreatments, mainly towards the end of
dialysis.dialysis.
A significant cause for early terminationA significant cause for early termination
and underdialysisand underdialysis..
17. Cause not entirely clear, but associatedCause not entirely clear, but associated
withwith
@-Hyponatraemia@-Hyponatraemia
@-Hypotension.@-Hypotension.
@-Hypovolaemia.@-Hypovolaemia.
@-Hypoxia.@-Hypoxia.
@-carnitine deficiency.@-carnitine deficiency.
Cramps are increased in patients usingCramps are increased in patients using
low sodium dialysate and requiringlow sodium dialysate and requiring
increased UF.increased UF.
18. ManagementManagement
@-Minimize interdialytic weight gain and need for@-Minimize interdialytic weight gain and need for
excessive UF.excessive UF.
@-prevent dialysis hypotension.@-prevent dialysis hypotension.
@-higher sodium dialysate, or sodium profiling.@-higher sodium dialysate, or sodium profiling.
@-Carnitine supplementation@-Carnitine supplementation
19. @-Acutely, intravenous saline (normal@-Acutely, intravenous saline (normal
or hypertonic) and intravenous 50%or hypertonic) and intravenous 50%
dextrose are very effective (but salinedextrose are very effective (but saline
will contribute to hypertension andwill contribute to hypertension and
volume overload).volume overload).
@-Local massage offers some relief.@-Local massage offers some relief.
21. CausesCauses
@-Common, and usually associated@-Common, and usually associated
with hypotension.with hypotension.
@-May be a minor manifestation of@-May be a minor manifestation of
disequilibrium syndrome due to excessdisequilibrium syndrome due to excess
urea removalurea removal
@-Patients with persistent marked@-Patients with persistent marked
uraemia.uraemia.
@-Rarely precipitated by caffeine or@-Rarely precipitated by caffeine or
alcohol withdrawal during dialysisalcohol withdrawal during dialysis..
22. ManagementManagement
@-Treat and prevent hypotension.@-Treat and prevent hypotension.
@-Antiemetics and paracetamol may help if@-Antiemetics and paracetamol may help if
not precipitated by hypotension.not precipitated by hypotension.
@-Reduction of blood flow rate (by 25-30%)@-Reduction of blood flow rate (by 25-30%)
during first hour of dialysis sometimes usefulduring first hour of dialysis sometimes useful
..
@-Use bicarbonate rather than acetate@-Use bicarbonate rather than acetate
dialysis.dialysis.
23. Chest painChest pain
Commonly caused by angina, but alsoCommonly caused by angina, but also
by hypotension, dialysis disequilibriumby hypotension, dialysis disequilibrium
syndrome, haemolysis, and airsyndrome, haemolysis, and air
embolism. Recurrent angina duringembolism. Recurrent angina during
dialysis should be investigateddialysis should be investigated
cardiologically, and can be treated withcardiologically, and can be treated with
B-blockers or nitrates .B-blockers or nitrates .
Both agents may cause hypotension.Both agents may cause hypotension.
24. Air embolismAir embolism
Rare, as air detectors will clamp venousRare, as air detectors will clamp venous
blood lines if air is detected in the returnblood lines if air is detected in the return
circuitcircuit
Introduction of 1 ml/kg air may be fatalIntroduction of 1 ml/kg air may be fatal..
25. In sitting patients air tends to move upwardsIn sitting patients air tends to move upwards
into cerebral venous circulation and causeinto cerebral venous circulation and cause
fitting and coma.fitting and coma.
In recumbent patients it causes chest pain,In recumbent patients it causes chest pain,
dyspnoea, chest tightness and cough, anddyspnoea, chest tightness and cough, and
may pass through the pulmonary vascularmay pass through the pulmonary vascular
bed and embolize into arterioles causingbed and embolize into arterioles causing
acute neurological signs.acute neurological signs.
Foam is usually seen in the venous bloodFoam is usually seen in the venous blood
line.line.
26. ManagementManagement
@-@-Clamp venous line and stop blood pump.Clamp venous line and stop blood pump.
@-Place patient in left lateral position, with@-Place patient in left lateral position, with
head and chest down.head and chest down.
@-Administer 100% O@-Administer 100% O22 (enhances nitrogen(enhances nitrogen
diffusion out of air bubbles), anddiffusion out of air bubbles), and
cardiopulmonary support as necessary.cardiopulmonary support as necessary.
@-Rarely, percutaneous aspiration of air@-Rarely, percutaneous aspiration of air
from the ventricle necessaryfrom the ventricle necessary..
27. HaemolysisHaemolysis
Severe haemolysis is rare, but can causeSevere haemolysis is rare, but can cause
chest pain, abdominal or back pain, chestchest pain, abdominal or back pain, chest
tightness, headache, nausea, and malaisetightness, headache, nausea, and malaise..
28. Life threatening hyperkalaemia can occur ifLife threatening hyperkalaemia can occur if
unrecognized.unrecognized.
Should especially be considered if severalShould especially be considered if several
patients complain of similar symptomspatients complain of similar symptoms
simultaneously.simultaneously.
Venous blood may develop a darkerVenous blood may develop a darker
appearance, and plasma will appear pink inappearance, and plasma will appear pink in
clotted or spun blood samples.clotted or spun blood samples.
Hb fallsHb falls..
29. CausesCauses ::
@-overheating of dialysate;@-overheating of dialysate;
@-contamination with bleach, formaldehyde,@-contamination with bleach, formaldehyde,
or peroxide from water purification oror peroxide from water purification or
reprocessing;reprocessing;
@-chloramine, nitrates, or copper from@-chloramine, nitrates, or copper from
water supply;water supply;
@-hypotonic dialysate;@-hypotonic dialysate;
@-kinks in blood tubing;@-kinks in blood tubing;
@-malfunctioning blood pump.@-malfunctioning blood pump.
30. ManagementManagement
Stop blood pump immediately andStop blood pump immediately and
clamp lines.clamp lines.
Risk of severe hyperkalaemia.Risk of severe hyperkalaemia.
Check potassium and Hb.Check potassium and Hb.
Haemolysis may continue for severalHaemolysis may continue for several
hours after removal of precipitant.hours after removal of precipitant.
Seek cause urgently, as multipleSeek cause urgently, as multiple
patients may be affected if it is due topatients may be affected if it is due to
water or a central dialysate problemwater or a central dialysate problem..